首页> 外文期刊>Acta Horticulturae >Progress towards the development of transgenic disease resistance in citrus.
【24h】

Progress towards the development of transgenic disease resistance in citrus.

机译:柑橘转基因抗病性发展的进展。

获取原文
获取原文并翻译 | 示例
           

摘要

Florida is the world's third largest producer of citrus, behind Brazil and China. This 9 billion dollar industry is now under siege by two important diseases - citrus greening, also known as huanglongbing (HLB), and citrus canker. Both these diseases are caused by gram negative bacteria. Canker is primarily affecting the grapefruit industry and poses problems with the establishment of new sweet orange groves. It can be managed by following a canker suppression program, whereas HLB affects all cultivated citrus varieties and cannot currently be controlled. Resistance to either HLB or canker is also not present in commercial orange and grapefruit cultivars. A major strategy is to develop resistant cultivars via genetic engineering by incorporating resistance genes not found in citrus. We have successfully cloned several natural and synthetic antibacterial genes and genes that have the potential to turn on SAR (Systemic Acquired Resistance) and made significant progress in introducing them into commercial sweet orange and grapefruit cultivars. We have regenerated hundreds of transgenic citrus plants, using both the standard Agrobacterium-mediated transformation system and the protoplast/GFP transformation system developed previously in our program. Genetic constructs containing promoters that target expression of the above gene(s) exclusively to the phloem tissue, where HLB resides, are also being utilized in efforts to minimize foreign gene expression in fruit or juice subsequently going to market. Progress towards the development and testing of such transgenic disease resistance in commercial citrus cultivars will be discussed.
机译:佛罗里达州是世界第三大柑橘生产国,仅次于巴西和中国。这个市值90亿美元的产业目前正受到两种重要疾病的困扰-柑橘绿化(又称黄龙病)和柑橘溃疡病。这两种疾病都是由革兰氏阴性细菌引起的。溃疡病主要影响葡萄柚产业,并在建立新的甜橙林带来问题。可以通过遵循抑制溃疡计划来对其进行管理,而HLB会影响所有栽培的柑橘品种,目前尚无法控制。在商业橙和葡萄柚品种中也没有对HLB或溃疡病的抗性。一种主要策略是通过整合柑橘中未发现的抗性基因,通过基因工程开发抗性品种。我们已经成功克隆了几种天然和合成的抗菌基因以及具有开启SAR(系统获得性抗药性)潜力的基因,并在将其引入商品甜橙和葡萄柚品种中取得了重大进展。我们已经使用标准的土壤杆菌介导的转化系统和之前在我们的程序中开发的原生质体/ GFP转化系统,再生了数百种转基因柑橘植物。包含启动子的基因构建体也被专门用于将上述基因的表达专门靶向HLB所在的韧皮部组织,以最小化随后进入市场的水果或果汁中的外源基因表达。将讨论在商业柑桔品种中开发和测试这种转基因抗病性的进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号